Elpida Therapeutics will be hosting an open virtual meeting via Zoom on Thursday,January 18, from 3-4 p.m. EST (8-9pm UK time), to provide an update on the ongoing gene therapy trial for treating CLN7 Batten disease, which has been led by the University of Texas Southwestern Medical Center.
Elpida will also be discussing their plans to expand the treatment to more patients in the future. Please note that this meeting is primarily for families affected by CLN7 disease but is open to all Batten families, researchers, clinicians, patient advocacy groups, etc. who would like to attend.
Join the Zoom meeting by clicking the link below:
Please contact Jo or Liz if you have any questions.